Feasibility of 90Y TOF PET-based dosimetry in liver metastasis therapy using SIR-Spheres
- 27 April 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 37 (9), 1654-1662
- https://doi.org/10.1007/s00259-010-1470-9
Abstract
Purpose 90Y-labelled compounds used in targeted radiotherapy are usually imaged with SPECT by recording the bremsstrahlung X-rays of the β decay. The continuous shape of the X-ray spectrum induces the presence of a significant fraction of scatter rays in the acquisition energy window, reducing the accuracy of biodistribution and of dosimetry assessments. Methods The aim of this paper is to use instead the low branch of e− e+ pair production in the 90Y decay. After administration of 90Y-labelled SIR-Spheres by catheterization of both liver lobes, the activity distribution is obtained by 90Y time-of-flight (TOF) PET imaging. The activity distribution is convolved with a dose irradiation kernel in order to derive the regional dosimetry distribution. Results Evaluation on an anatomical phantom showed that the method provided an accurate dosimetry assessment. Preliminary results on a patient demonstrated a high-resolution absorbed dose distribution with a clear correlation with tumour response. Conclusion This supports the implementation of 90Y PET in selective internal radiation therapy of the liver.Keywords
This publication has 40 references indexed in Scilit:
- MIRD Pamphlet No. 20: The Effect of Model Assumptions on Kidney Dosimetry and Response—Implications for Radionuclide TherapyJournal of Nuclear Medicine, 2008
- Three-Dimensional Imaging-Based Radiobiological DosimetrySeminars in Nuclear Medicine, 2008
- Posttherapy Radiation Safety Considerations in Radiomicrosphere Treatment with 90Y-MicrospheresJournal of Nuclear Medicine, 2007
- Clinical radionuclide therapy dosimetry: the quest for the “Holy Gray”European Journal of Nuclear Medicine and Molecular Imaging, 2007
- Clinical applications of newer radionuclide therapiesEuropean Journal Of Cancer, 2006
- Quantitative Imaging Of Yttrium-86 Pet with the Ecat Exact Hr+ In 2D ModeCancer Biotherapy & Radiopharmaceuticals, 2004
- Beta voxel S values for internal emitter dosimetryMedical Physics, 2003
- Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA0,d-Phe1,Tyr3]octreotide, a promising somatostatin analogue for radionuclide therapyEuropean Journal of Nuclear Medicine and Molecular Imaging, 1997
- Preclinical evaluation of intravenously administered 111in- and 90y-labeled b72.3 immunoconjugate (GYK-DTPA) in beagle dogsNuclear Medicine and Biology, 1993
- Zum experimentellen Nachweis von Zweiquantenzerfall beim 0+-0+- bergang des Zr90The European Physical Journal A, 1961